AstraZeneca Seeks Tax-Free Drug Production in Indiana Trade Zone
Published Date: 4/3/2025
Notice
Summary
AstraZeneca wants to start making a new medicine called zibotentan/dapagliflozin tablets at their Mount Vernon, Indiana site inside a special trade zone. This move lets them handle certain imported ingredients with lower or no import taxes, saving money and speeding up production. People have until May 13, 2025, to share their thoughts before the plan gets the green light.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Duty-Free Finished Tablets in FTZ 177
AstraZeneca notified the FTZ Board it would produce zibotentan/dapagliflozin tablets at its FTZ 177 Subzone 177A facility in Mount Vernon, Indiana. The notice lists the finished tablets as duty-free when produced under Foreign-Trade Zone procedures.
Zibotentan API: 6.5% Duty and IEEPA Status
The zibotentan active pharmaceutical ingredient is identified as a foreign-status material with a listed duty rate of 6.5%. The notice also states the API may be subject to duties under section 1702 of the International Emergency Economic Powers Act depending on country of origin, and applicable section 1702 decisions require such merchandise to be admitted to FTZs in privileged foreign status under 19 CFR 146.41.
Public Comment Deadline May 13, 2025
Interested parties may submit public comments on the proposed FTZ production activity; submissions must be received by May 13, 2025. Comments should be addressed to the FTZ Board's Executive Secretary at the email provided in the notice.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in